Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Baseline to Six Months	STARTED	Rituximab	13
Baseline to Six Months	STARTED	Placebo	12
Baseline to Six Months	COMPLETED	Rituximab	11
Baseline to Six Months	COMPLETED	Placebo	10
Baseline to Six Months	NOT COMPLETED	Rituximab	2
Baseline to Six Months	NOT COMPLETED	Placebo	2
Six Months to Twelve Months	STARTED	Rituximab	11
Six Months to Twelve Months	STARTED	Placebo	10
Six Months to Twelve Months	COMPLETED	Rituximab	10
Six Months to Twelve Months	COMPLETED	Placebo	9
Six Months to Twelve Months	NOT COMPLETED	Rituximab	1
Six Months to Twelve Months	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00595335/flow